InMed PharmaceuticalsINM 
$4.406.26%24h
6.26%24h
Global rank25985
Market cap$10.77M
Change 7d-13.95%
YTD Performance999.75%
SP500 benchmarkOutperform
P/E-1.35
P/S2.60
Revenue$4.14M
Earnings-$7.95M
Dividend yield-
Main Sector
Healthcare
InMed Pharmaceuticals Revenue data
According to InMed Pharmaceuticals latest financial reports the company had revenue of $4.14M in 2023-06-30, a 279.61% increase from 2022. InMed Pharmaceuticals highest revenue was $4.14M in 2023.
Revenue history for InMed Pharmaceuticals from 2020 to 2024
-
Value:-
InMed Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $4.14M | 279.61% |
| 2022 | $1.09M | Infinity% |
| 2021 | $0 | NaN% |
| 2020 | $0 | - |
View the top revenue stocks 
